Investor Presentaiton slide image

Investor Presentaiton

31st January 2024 Market diversification in Branded Generics enables continued growth Metoprolol Succinate Extended Release Tablets USP Met XL 25 alanta Metoprolol Succinate Extended Release Tablets USP Met XL 100 janta Melacare+ Artefan 80/480 Artemether 80 mg and Lumefantrine 480 mg Tes Comprimés d'artmeter 80 mg et de lunefarine 480 mg Artefan so/480 Sitaprit MZD GC Tablet Sitapril M 50/1000) atsalipin & Motormin Hynchbu T1000 20g Langghting Ceam ajanta Plus Melacare+ Skin Lightening and Brightening Cream Rx 20 g 03 ajanta 10 ml Corboxymethylcellulose Sedium and Glerin Eye Drops Sodium de Carboxymethylcellule et Glycin Gutres Pour Softdrops ajante 10 x 10 Tablets Febuxostat Tablets 80 mg Feburic 80 ajanta 3 India Africa Regions Asia Chronic Therapies in focus Cardiac Diabetics Ophthal Derma Pain Leadership In Molecules & Sub- Therapeutic Segments 7 ajanta
View entire presentation